Passage Bio Stock Short Ratio

PASG Stock  USD 0.62  0.11  21.57%   
Passage Bio fundamentals help investors to digest information that contributes to Passage Bio's financial success or failures. It also enables traders to predict the movement of Passage Stock. The fundamental analysis module provides a way to measure Passage Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Passage Bio stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Passage Bio Company Short Ratio Analysis

Passage Bio's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Short Ratio

 = 

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis

Current Passage Bio Short Ratio

    
  6.61 X  
Most of Passage Bio's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Passage Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Passage Short Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Passage Bio is extremely important. It helps to project a fair market value of Passage Stock properly, considering its historical fundamentals such as Short Ratio. Since Passage Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Passage Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Passage Bio's interrelated accounts and indicators.
1.00.89-0.56-0.690.87-0.581.01.00.990.830.69-0.88-0.54-0.150.580.29
1.00.86-0.6-0.670.85-0.641.01.00.990.820.66-0.85-0.51-0.150.550.28
0.890.86-0.26-0.780.85-0.220.860.870.850.890.77-0.96-0.67-0.340.720.28
-0.56-0.6-0.26-0.13-0.550.79-0.6-0.61-0.63-0.150.110.13-0.29-0.460.190.31
-0.69-0.67-0.78-0.13-0.480.17-0.67-0.63-0.61-0.94-0.980.910.970.74-0.96-0.63
0.870.850.85-0.55-0.48-0.270.850.870.870.680.56-0.73-0.370.150.47-0.04
-0.58-0.64-0.220.790.17-0.27-0.64-0.6-0.62-0.35-0.120.260.040.03-0.05-0.1
1.01.00.86-0.6-0.670.85-0.641.00.990.820.66-0.85-0.51-0.150.550.28
1.01.00.87-0.61-0.630.87-0.61.01.00.790.63-0.84-0.46-0.090.510.27
0.990.990.85-0.63-0.610.87-0.620.991.00.770.61-0.83-0.44-0.070.480.26
0.830.820.89-0.15-0.940.68-0.350.820.790.770.92-0.95-0.88-0.590.910.41
0.690.660.770.11-0.980.56-0.120.660.630.610.92-0.88-0.95-0.640.970.61
-0.88-0.85-0.960.130.91-0.730.26-0.85-0.84-0.83-0.95-0.880.810.52-0.83-0.48
-0.54-0.51-0.67-0.290.97-0.370.04-0.51-0.46-0.44-0.88-0.950.810.77-0.98-0.54
-0.15-0.15-0.34-0.460.740.150.03-0.15-0.09-0.07-0.59-0.640.520.77-0.73-0.67
0.580.550.720.19-0.960.47-0.050.550.510.480.910.97-0.83-0.98-0.730.5
0.290.280.280.31-0.63-0.04-0.10.280.270.260.410.61-0.48-0.54-0.670.5
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition

Based on the latest financial disclosure, Passage Bio has a Short Ratio of 6.61 times. This is 69.49% higher than that of the Biotechnology sector and 10.8% lower than that of the Health Care industry. The short ratio for all United States stocks is 65.25% lower than that of the firm.

Passage Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Passage Bio's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Passage Bio could also be used in its relative valuation, which is a method of valuing Passage Bio by comparing valuation metrics of similar companies.
Passage Bio is currently under evaluation in short ratio category among its peers.

Passage Bio Institutional Holders

Institutional Holdings refers to the ownership stake in Passage Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Passage Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Passage Bio's value.
Shares
Fiduciary Trust Co2024-09-30
215 K
Rbf Llc2024-06-30
142.8 K
State Street Corp2024-06-30
123.9 K
Two Sigma Investments Llc2024-09-30
98 K
Marquette Asset Management Inc.2024-06-30
85.5 K
Landscape Capital Management,llc2024-09-30
53.9 K
Northern Trust Corp2024-09-30
40.3 K
Engineers Gate Manager Lp2024-09-30
34.8 K
Xtx Topco Ltd2024-09-30
29.6 K
Orbimed Advisors, Llc2024-06-30
10.1 M
Vestal Point Capital Lp2024-06-30
6.1 M

Passage Fundamentals

About Passage Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Passage Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Passage Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Passage Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Passage Bio is a strong investment it is important to analyze Passage Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Passage Bio's future performance. For an informed investment choice regarding Passage Stock, refer to the following important reports:
Check out Passage Bio Piotroski F Score and Passage Bio Altman Z Score analysis.
For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.17)
Return On Assets
(0.34)
Return On Equity
(0.64)
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.